Short stature due to a defect in growth hormone receptor or post receptor pathway (Q97202): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| (One intermediate revision by the same user not shown) | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
15 August 2026
| |||||||||||||||
| Property / Collection date: 15 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 13:15, 16 August 2026
Growth hormone insensitivity syndrome (GHIS) is a group of diseases characterised by marked short stature associated with normal or elevated growth hormone (GH) concentrations, which fail to respond to exogenous GH administration. GHIS comprises growth delay due to IGF-1 deficiency, growth delay due to IGF-1 resistance, Laron syndrome, short stature due to STAT5b deficiency and primary acid-labile subunit (ALS) deficiency (see these terms).
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_510125881 |
||
| English | Short stature due to a defect in growth hormone receptor or post receptor pathway |
Growth hormone insensitivity syndrome (GHIS) is a group of diseases characterised by marked short stature associated with normal or elevated growth hormone (GH) concentrations, which fail to respond to exogenous GH administration. GHIS comprises growth delay due to IGF-1 deficiency, growth delay due to IGF-1 resistance, Laron syndrome, short stature due to STAT5b deficiency and primary acid-labile subunit (ALS) deficiency (see these terms). |
Statements
CID11:ID_510125881
0 references
dki-india-ID_510125881
0 references
Concluído
0 references
15 August 2026
0 references
